Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng-Fung Lin

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Molecular Carcinogenesis|April 30, 2008
Disturbance of circadian gene expression in hepatocellular carcinomaYueh-Min Lin, Julia H Chang, Kun-Tu Yeh, et al.
Japanese Journal of Clinical Oncology|May 31, 2012
Comparison of clinical outcome of breast cancer patients with T1-2 tumor and one to three positive nodes with or without postmastectomy radiation therapyChih-Jen Huang, Ming-Feng Hou, Hung-Yi Chuang, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|November 21, 2009
Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinomaPi-Chuan Hsieh, Yuk-Kwan Chen, Kun-Bow Tsai, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2004
Dihydropyrimidine dehydrogenase pharmacogenetics in the Taiwanese populationHui-Hua Hsiao, Ming-Yu Yang, Jan-Gowth Chang, et al.
Annals of Hematology|October 31, 2013
Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxisCheng-Han Wu, Po-Liang Lu, Hui-Hua Hsiao, et al.
Journal of Biomedical Science|August 15, 2013
Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemiaWen-Chi Yang, Wan-Chi Tsai, Pai-Mei Lin, et al.
Oncology Reviews|March 13, 2019
Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myelomaShang-Yi Huang, Tsai-Yun Chen, Ching-Yuan Kuo, et al.
BMC Immunology|September 27, 2014
Effects of the mTOR inhibitor rapamycin on monocyte-secreted chemokinesHugo You-Hsien Lin, Kai-Ting Chang, Chi-Chih Hung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Impact of donor characteristics and HLA matching on survival of chinese patients with hematologic malignancies undergoing unrelated hematopoietic stem cell transplantationTso-Fu Wang, He Huang, Cheng-Hwai Tzeng, et al.
Clinical Biochemistry|July 14, 2007
Antioxidant status and superoxide anion radical generation in acute myeloid leukemiaTze-Kiong Er, Shih-Meng Tsai, Szu-Hsien Wu, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Molecular Carcinogenesis|April 30, 2008
Disturbance of circadian gene expression in hepatocellular carcinomaYueh-Min Lin, Julia H Chang, Kun-Tu Yeh, et al.
Japanese Journal of Clinical Oncology|May 31, 2012
Comparison of clinical outcome of breast cancer patients with T1-2 tumor and one to three positive nodes with or without postmastectomy radiation therapyChih-Jen Huang, Ming-Feng Hou, Hung-Yi Chuang, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|November 21, 2009
Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinomaPi-Chuan Hsieh, Yuk-Kwan Chen, Kun-Bow Tsai, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2004
Dihydropyrimidine dehydrogenase pharmacogenetics in the Taiwanese populationHui-Hua Hsiao, Ming-Yu Yang, Jan-Gowth Chang, et al.
Annals of Hematology|October 31, 2013
Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxisCheng-Han Wu, Po-Liang Lu, Hui-Hua Hsiao, et al.
Journal of Biomedical Science|August 15, 2013
Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemiaWen-Chi Yang, Wan-Chi Tsai, Pai-Mei Lin, et al.
Oncology Reviews|March 13, 2019
Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myelomaShang-Yi Huang, Tsai-Yun Chen, Ching-Yuan Kuo, et al.
BMC Immunology|September 27, 2014
Effects of the mTOR inhibitor rapamycin on monocyte-secreted chemokinesHugo You-Hsien Lin, Kai-Ting Chang, Chi-Chih Hung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Impact of donor characteristics and HLA matching on survival of chinese patients with hematologic malignancies undergoing unrelated hematopoietic stem cell transplantationTso-Fu Wang, He Huang, Cheng-Hwai Tzeng, et al.
Clinical Biochemistry|July 14, 2007
Antioxidant status and superoxide anion radical generation in acute myeloid leukemiaTze-Kiong Er, Shih-Meng Tsai, Szu-Hsien Wu, et al.
Pageof 13